Persistently elevated inflammatory markers (IL-6 and CRP) were risk factors for unfavorable outcomes, while low serum anti-S1/S2 IgG and ambulatory acute COVID-19 correlated with better recovery [57]. This evidence concerns the gene CRP and COVID-19.